Mesenchymal stem cells, aging and regenerative medicine

Muscles, Ligaments and Tendons Journal

Volumn 2, Issue 3, 2012, Pages 239-242

  Raggi, Chiara ^a   Berardi, Anna C ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SPIRITO SANTO HOSPITAL   (Italy)

Author keywords

Aging; Mesenchymal stem cells (MSCs); Regenerative medicine; Stem cells

Indexed keywords

EID: 84892841556     PISSN: None     EISSN: 22404554     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Drummond-Barbosa D. Stem cells, their niches and the systemic environment: an aging network. Genetics 2008 180: p. 1787-1797.
2. Ferraro F, Celso CL, Scadden D. Adult stem cels and their niches. Adv Exp Med Biol 2010. 695: p. 155-168.
3. Rando TA. Stem cells, ageing and the quest for immortality. Nature 2006. 441: p. 1080-1086.
4. Bellantuono I. Aging of marrow stromal (skeletal) stem cells and their contribution to age-related bone loss. Biochim Biophys Acta, 2009. 1792: p. 364-370.
5. Jones DL, Rando TA. Emerging models and paradigms for stem cell ageing. Nat Cell Biol 2011. 13: p. 506-512.
6. Mendez-Ferrer S et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010. 466: p. 829-834.
7. Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012. 481: p. 457-462.
8. da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells-2008. 26: p. 2287-2299.
9. Crisan M et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008. 3: p. 301-313.
10. Kawai M, Devlin MJ, Rosen CJ. Fat targets for skeletal health. Nat Rev Rheumatol, 2009. 5: p. 365-372.
11. Ozcivici E, Luu YK, Adler B et al. Mechanical signals as anabolic agents in bone. Nat Rev Rheumatol 2010. 6: p. 50-59.
12. Laschober GT et al. Age-specific changes of mesenchymal stem cells are paralleled by upregulation of CD106 expression as a response to an inflammatory environment. Rejuvenation Res 2011. 14: p. 119-131.
13. Fehrer C, Lepperdinger G. Mesenchymal stem cell aging. Exp Gerontol, 2005. 40: p. 926-930.
14. Brandl A, Meyer M, Bechmann V, Nerlich M, Angele P. Oxidative stress induces senescence in human mesenchymal stem cells. Exp Cell Res 2011. 317: p. 1541-1547.
15. Fehrer C et al. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 2007. 6: p. 745-757.
16. Kasper G et al. Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton. Stem Cells 2009. 27: p. 1288-1297.
17. Stolzing A, Jones E, Mcgonagle D, Scutt A. Age-related changes in human bone, marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 2008. 129: p. 163-173.
18. Kemp K, Gray E, Mallam E, Scolding N, Wilkins A. Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells. Stem Cell Rev 2010. 6: p. 548-559.
19. Laschober GT et al. Identification of evolutionarily conserved genetic regulators of cellular aging. Aging Cell 2010. 9: p. 1084-1097.
20. Bork S, Pfister S, Witt H et al. DNA methylation pattern changes upon, long-term culture and aging of human mesenchymal stromal cells. Aging Cell, 2010. 9: p. 54-63.
21. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999. 14: p. 1115-1122.
22. Hoerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. Aging activates adipogenic and Crerki K, suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 2004. 3: p. 379-389.
23. Zhou S et al. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 2008. 7: p. 335-343.
24. de Gonzalo-Calvo D et al. Differential inflammatory responses in aging and disease: TNF-alpha and IL-6 as possible biomarkers. Free Radic Biol Med 2010. 49: p. 733-737.
25. Duque G, Huang DC, Macoritto M et al. Autocrine regulation of interferon, gamma in mesenchymal stem cells plays a role in early osteoblastogenesis. Stem Cells, 2009 27: p. 550-558.
26. Hardy R, Cooper MS, Bone loss in inflammatory disorders. J Endocrinol 2009. 201: p. 309-20.
27. Mohanty ST et al. Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis. Arthritis Res Ther 2010. 12: p. 149-61.
28. Franceschi C et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007. 128: p. 92-105.
29. Laschober GT, Brunaver R, Jamnig A, Fehrer C, Greiderer B, Lepperdinger G. Leptin receptor/CD295 is upregulated on primary human mesenchymal stem cells of advancing biological age and distinctly marks the subpopulation of dying cells. Exp Gerontol 2009. 44: p. 57-62.
30. Choumerianou DM, Martimianaki G, Shakaki E, Kalmanti L, Kalmanti M, Dimitriou M. Comparative study of stemness characteristics of mesenchymal cells from bone marrow of children and adults. Cytotherapy 2010. 12: p. 881-7.
31. Wagner W et al. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One, 2009. 4: p. 5846-59.
32. Mimeault M, Hauke R, Batra SK. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 2007. 82: p. 252-64.
33. Blanc KL et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008. 371: p.1579-86.
34. Ringden O et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation, 2006. 81: p.1390-97.
35. Garcia-Castro J, Trigueros C, Madrenas J, Pérez-Simon, Rodriguez R, Menendez P. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. J Cell Mol Med 2008. 12: p. 2552-65.
36. Wagner W, Ho AD, Zenke M. Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev 2010.16: p.445-53.
37. Nagaya N et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005. 112: p. 1128-35.
38. Dominici M et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006. 8: p.315-17.
39. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol, 2006. 7: p. 14-21.
40. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998. 396: p.84-8.
41. Ho AD, Wagner W, Mahlknecht U. Stem cells and ageing. The potential of stem cells to overcome agerelated deteriorations of the body in regenerative medicine. EMBO Rep, 2005. 6:p.35-8.
42. Janzen V et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 2006. 443: p.421-26.
43. Madeira A, da Silva CL, Dos Santos F, Comofeita E, Cabrol JM, Sà-Correia I. Madeira A et al. Human Mesenchymal Stem Cell Expression Program upon Extended Ex-Vivo Cultivation, as Revealed by 2-DE-Based Quantitative Proteomics. Plos one 2012. 8: p.43523-39.